Non‐conventional starch nanoparticles for drug delivery applications

TL;DR: A review of the use of biopolymeric nanoparticles of animal, plant, algal, fungal, and bacterial origin as a sustainable material for potential use as drug delivery systems is presented in this paper .

TL;DR: The current study focuses on starch nanoparticle manufacturing, characterization, and emerging applications and focuses on Nano-precipitation and ultra-sonication.

TL;DR: The limitation of conventional drug delivery systems such as specificity, bioavailability, biocompatibility, biodegradability, and parenteral administration have been overcome with the advent of nanomaterials as cargo for targeted drug delivery to combat communicable and non-communicable diseases as discussed by the authors .

TL;DR: A novel ionic liquid microemulsion consisting of 1-octyl-3-methylimidazolium acetate ([Omim]Ac, an Ionic liquid), native corn starch, surfactant TX-100, 1-butanol and cyclohexane was prepared.

TL;DR: The findings suggest that encapsulation of CG-1521 into starch nanoparticles can improve drug delivery of histone deacetylase inhibitors for breast cancer therapy without interfering with the mechanism of action of the drug.

TL;DR: In this article, a novel oral protein drug delivery made of starch nanoparticles (SNPs) as backbone and poly ( l -glutamic acid) (PGA) as graft chains was successfully synthesized by click reaction.

TL;DR: Fluorescein 5(6)-isothiocyanate starch maleate (FISM) nanoparticles with a mean particle size of 87 nm were formed via selfassembly upon precipitation in ethanolic solution.